SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-17-002726
Filing Date
2017-06-08
Accepted
2017-06-08 17:00:25
Documents
3
Period of Report
2017-06-07
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctxr_8k.htm 8-K 12710
2 CERTIFICATE OF AMENDMENT ctxr_ex31.htm EX-3.1 9249
3 PRESS RELEASE ctxr_ex991.htm EX-99.1 8514
  Complete submission text file 0001477932-17-002726.txt   31820
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55532 | Film No.: 17900775
SIC: 2834 Pharmaceutical Preparations